Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Psychiatrists at any stage in their training in the UK who wish to do a DPhil (PhD) can apply for this prestigious scheme which pays an appropriate clinical salary, fees, and research costs, for three years. Up to four places are available.

We are looking for the next generation of academic psychiatrists. Full details of the programme, potential supervisors, example projects, and how to apply, can be found here.

Fellows will receive training in a range of methods, and will conduct research leading to the award of a D.Phil. in their chosen area. Fellowships are for three years and include fees, clinical salary, and support for research costs. The programme places strong emphasis on translational research, and Fellows will have the opportunity to spend a day a week in a clinical unit specialising in translating research findings into routine care.

The deadline for applications is 8 January 2016 but you are advised to contact potential supervisors as soon as possible to discuss the scheme and develop a suitable project. Successful candidates will start in Autumn 2016. However, You can also contact Professor Paul Harrison (paul.harrison@psych.ox.ac.uk) for advice and further information.

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.